Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment

被引：0
|
作者：
Bai, Samantha H. [1 ]
Chandnani, Arun [1 ]
Cao, Siyan [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA
来源：
BIOMEDICINES | 2024年 / 12卷 / 12期
关键词：
bile acids; inflammatory bowel disease; ulcerative colitis; Crohn's disease; pathogenesis; new therapies; FARNESOID X RECEPTOR; PRIMARY SCLEROSING CHOLANGITIS; GUT MICROBIOTA; INTESTINAL INFLAMMATION; URSODEOXYCHOLIC ACID; ULCERATIVE-COLITIS; MICE; METABOLITES; REVEAL; ASSOCIATION;
D O I：
10.3390/biomedicines12122910
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Inflammatory bowel disease (IBD) is a chronic condition that affects about 7 million people worldwide, and new therapies are needed. Understanding the complex roles that bile acids (BAs) play in IBD may lead to the development of novel IBD treatments independent of direct immunosuppression. This review discusses the latest discoveries in the roles BAs play in IBD pathogenesis and explores how these discoveries offer promising new therapeutic targets to treat IBD and improve patient outcomes. Several therapies discussed include specific BA receptor (BAR) agonists, dietary therapies, supplements, probiotics, and mesenchymal stem cell therapies that have all been shown to decrease IBD disease activity.
引用
收藏
页数：24
相关论文
共 50 条
  • [1] Role of bile acids in inflammatory bowel disease
    Tiratterra, Elisa
    Franco, Placido
    Porru, Emanuele
    Katsanos, Konstantinos H.
    Christodoulou, Dimitrios K.
    Roda, Giulia
    ANNALS OF GASTROENTEROLOGY, 2018, 31 (03): : 266 - 272
  • [2] Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment
    Faggiani, Ilaria
    Fanizza, Jacopo
    D'Amico, Ferdinando
    Allocca, Mariangela
    Zilli, Alessandra
    Parigi, Tommaso Lorenzo
    Barchi, Alberto
    Danese, Silvio
    Furfaro, Federica
    BIOMEDICINES, 2024, 12 (08)
  • [3] Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
    Jiryeon Jang
    Sehoon Jeong
    BioChip Journal, 2023, 17 : 403 - 430
  • [4] Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
    Jang, Jiryeon
    Jeong, Sehoon
    BIOCHIP JOURNAL, 2023,
  • [5] Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
    Jang, Jiryeon
    Jeong, Sehoon
    BIOCHIP JOURNAL, 2023, 17 (04) : 403 - 430
  • [6] Bile acids as signaling molecules in inflammatory bowel disease: Implications for treatment strategies
    Ma, Yueyue
    Yang, Haoze
    Wang, Xiaoming
    Huang, Yuhong
    Li, Yuhong
    Pan, Guixiang
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 337
  • [7] Bile Acids Activated Receptors in Inflammatory Bowel Disease
    Biagioli, Michele
    Marchiano, Silvia
    Carino, Adriana
    Di Giorgio, Cristina
    Santucci, Luca
    Distrutti, Eleonora
    Fiorucci, Stefano
    CELLS, 2021, 10 (06)
  • [8] Inflammatory bowel disease. Pathophysiology and medical treatment
    von Ritter, C
    RADIOLOGE, 1998, 38 (01): : 3 - 7
  • [9] The role of bile acids in mediating fibrosis in inflammatory bowel disease
    Hazel, K.
    McGinley, N.
    O'Toole, A.
    Keely, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S187 - S187
  • [10] SERUM-BILE-ACIDS IN INFLAMMATORY BOWEL-DISEASE
    MIHAS, AA
    GIBSON, RG
    LEVY, N
    HIRSCHOWITZ, BI
    LANCET, 1977, 2 (8034): : 405 - 406
12345